Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Roivant Sciences (ROIV) Other Operating Expenses: 2020-2025

Historic Other Operating Expenses for Roivant Sciences (ROIV) over the last 5 years, with Sep 2025 value amounting to $111,000.

  • Roivant Sciences' Other Operating Expenses fell 52.56% to $111,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $758,000, marking a year-over-year decrease of 94.88%. This contributed to the annual value of $911,000 for FY2025, which is 96.75% down from last year.
  • Per Roivant Sciences' latest filing, its Other Operating Expenses stood at $111,000 for Q3 2025, which was down 27.92% from $154,000 recorded in Q2 2025.
  • In the past 5 years, Roivant Sciences' Other Operating Expenses ranged from a high of $101.3 million in Q4 2022 and a low of $111,000 during Q3 2025.
  • For the 3-year period, Roivant Sciences' Other Operating Expenses averaged around $4.0 million, with its median value being $223,500 (2024).
  • As far as peak fluctuations go, Roivant Sciences' Other Operating Expenses skyrocketed by 9,196.78% in 2021, and later plummeted by 99.81% in 2023.
  • Roivant Sciences' Other Operating Expenses (Quarterly) stood at $17.5 million in 2021, then soared by 479.42% to $101.3 million in 2022, then slumped by 99.81% to $197,000 in 2023, then spiked by 31.47% to $259,000 in 2024, then crashed by 52.56% to $111,000 in 2025.
  • Its Other Operating Expenses was $111,000 in Q3 2025, compared to $154,000 in Q2 2025 and $259,000 in Q4 2024.